Lack of Role for Nitric Oxide (NO) in the Selective Destabilization of Endothelial NO Synthase mRNA by Tumor Necrosis Factor–α
- 1 January 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (1), 52-57
- https://doi.org/10.1161/01.atv.15.1.52
Abstract
The constitutive expression of endothelial nitric oxide (NO) synthase (cNOS) is essential for the physiological regulation of vascular tone and structure. The mechanism of downregulation of steady state cNOS mRNA in human umbilical vein endothelial cells exposed to tumor necrosis factor–α (TNF-α) was investigated by using Northern blot analysis of total cellular RNA. TNF-α produced a dose- and time-dependent decrease in cNOS mRNA expression that was near maximal at 10 U/mL and 6 hours of exposure, respectively. In contrast, steady state expression of endothelin-1 and plasminogen activator inhibitor–1 (PAI-1) mRNA was upregulated by TNF-α. The pharmacological generation of NO using sodium nitroprusside (10 μmol/L) and S-nitroso-acetylpenicillamine (100 to 400 μmol/L) had no effect on cNOS mRNA levels, and TNF-α–induced downregulation of cNOS was not prevented by coincubation with the inhibitors of NO synthesis Nω-nitro-l-arginine methyl ester (1 mmol/L) and NG-monomethyl l-arginine (10 mmol/L). Under control conditions, cNOS and PAI-1 mRNA were stable after treatment with actinomycin D for periods greater than 24 hours, whereas endothelin-1 message was rapidly degraded (half-life, <1 hour). Pretreatment with TNF-α (30 U/mL) selectively reduced the half-life of cNOS mRNA to less than 12 hours without altering the stability of PAI-1 message. TNF-α–induced destabilization of cNOS mRNA could be partially prevented by coincubation with cycloheximide (1 μmol/L) but was not reproduced by addition of sodium nitroprusside. These findings indicate that TNF-α downregulation of cNOS expression in human endothelial cells results predominantly from the selective destabilization of the mRNA by a mechanism involving the synthesis of new protein. However, NO production by a TNF-α–inducible isoform of NOS did not appear to contribute either to the decrease in steady state cNOS mRNA levels or the shortening of its half-life.Keywords
This publication has 32 references indexed in Scilit:
- Messenger RNA degradation in eukaryotesCell, 1993
- Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated regionCell, 1993
- Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.Journal of Clinical Investigation, 1992
- Molecular cloning and characterization of human endothelial nitric oxide synthaseFEBS Letters, 1992
- The induction of nitric oxide synthase activity is inhibited by TGF-β1, PDGFAB and PDGFBB in vascular smooth muscle cellsEuropean Journal of Pharmacology, 1992
- Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophagesBiochemical and Biophysical Research Communications, 1991
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990
- cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.Journal of Clinical Investigation, 1986
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973